{"entity":{"id":"nct05776524","kind":"trial","name":"Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer","aka":[],"tldr":"A phase 2 trial of nab-paclitaxel and gemcitabine in pancreatic cancer, run by THERABIONIC INC., now recruiting.","summary":"Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer is a phase 2, interventional study registered as NCT05776524 by THERABIONIC INC., with a registry enrolment figure of 46 participants, started 2023-06-13 and due to reach its primary completion in 2027-07. Interventions recorded: Nab paclitaxel; Gemcitabine; TheraBionic. Conditions listed: Pancreatic Cancer; Metastatic Adenocarcinoma. Primary outcome: Overall Survival. Pancreatic eligibility wording from the registry: \"* Patient must have newly diagnosed untreated biopsy proven metastatic adenocarcinoma of the pancreas\". Sites: United States. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT05776524","url":"https://clinicaltrials.gov/study/NCT05776524"}],"tags":["ctgov-ingest","pancreatic-deep-dive"],"related":[],"cancers":["metastatic-pdac"],"sections":[],"technologies":["cytotoxic-chemotherapy"],"targets":[],"drugs":["nab-paclitaxel","gemcitabine"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05776524","phase":"2","setting":"A Phase 2 Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer","sponsor":"THERABIONIC INC.","enrolled":46,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05776524/","neighbours":{"cancer":[{"id":"metastatic-pdac","kind":"cancer","name":"Metastatic pancreatic ductal adenocarcinoma","route":"/cancers/metastatic-pdac/"}],"technology":[{"id":"cytotoxic-chemotherapy","kind":"technology","name":"Cytotoxic chemotherapy","route":"/technologies/cytotoxic-chemotherapy/"}],"drug":[{"id":"gemcitabine","kind":"drug","name":"Gemcitabine","route":"/drugs/gemcitabine/"},{"id":"nab-paclitaxel","kind":"drug","name":"Nab-paclitaxel","route":"/drugs/nab-paclitaxel/"}],"term":[{"id":"pancreatic-trials-open-today","kind":"term","name":"Pancreatic cancer trials open today (registry snapshot and UK sites)","route":"/terms/pancreatic-trials-open-today/"}]}}